Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


J&J/Boston Sci battle persists

This article was originally published in The Gray Sheet

Executive Summary

A federal judge allows Johnson & Johnson to pursue a breach of contract claim against Boston Scientific alleging Guidant violated its 2004 merger deal with J&J when its shareholders decided to be acquired by Boston Scientific instead. In an Aug. 29 1ruling, Southern District of New York Judge Gerard Lynch denied Boston Scientific/Guidant's motion to dismiss the breach of contract claims initiated in October 2006 by J&J as part of a $5.5 billion suit. However, he did dismiss J&J's claims that Boston Scientific improperly interfered with J&J's efforts to buy Guidant and that Guidant breached its "implied duty of good faith and fair dealing" when it decided to accept Boston Scientific's merger offer (2"The Gray Sheet' Oct. 2, 2006, p. 6). The judge also dismissed all of J&J's claims against Abbott Laboratories, whose acquisition of Guidant's stent business helped fund Boston Scientific's Guidant purchase and made it easier for antitrust regulators to clear the deal...



Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts